Abstract
Cord blood (CB) is an unlimited source of hematopoietic stem and progenitor cells (HSPC). The use of cryopreserved CB-derived CD34+ HSPCs is successful in children and usually leads to rapid hematopoietic recovery upon transplantation. However, current methods for ex vivo expansion of HSPCs still result in a loss of multilineage differentiation potential and current freeze-thawing protocols result in significant cell death and loss of CD34+ HSPCs. The major cause for the loss of viability after slow freezing is apoptosis induced directly by cryoinjury. Very recent reports have demonstrated that Y-27632, a selective and robust ROCK inhibitor is a potent inhibitor of the apoptosis and is efficient in enhancing the post-thaw survival and recovery of different human stem cells including human embryos, hESCs, induced pluripotent stem cells and mesenchymal stem cells. Here, we analyzed the effect of such an inhibitor in CB-derived CD34+ HSPCs. CB-derived CD34+ HSPCs were MACS-isolated and treated with or without 10 μM of Y-27632. The effect of Y-27632 on culture homeostasis was determined in both fresh and cryopreserved CB-derived CD34+ HSPCs. Our results indicate that the Y-27632 not only dramatically inhibits cell expansion of both fresh and cryopreserved CD34+ HSPCs but also impairs survival/recovery of CD34+ HSPCs upon thawing regardless whether Y-27632 is added to both the cryopreservation and the expansion media and or just to the expansion culture medium with or without hematopoietic cytokines. This study identifies for the first time a detrimental effect of Y-27632 on the expansion and survival of both fresh and cryopreserved CB-derived CD34+ HSPCs, suggesting that Y-27632 may have a differential impact on distinct lineage/tissue-specific stem cells. Our data suggest different functions of Y-27632 on human stem cells growing in suspension versus those growing attached to either treated tissue culture plastic or extracellular matrix. We discourage any clinical application of Y-27632 in potential technical developments aimed at improving cryopreservation procedures of CB-derived cells and/or in vitro expansion of HSPCs without spontaneous differentiation.
References
Gluckman, E., & Rocha, V. (2009). Cord blood transplantation: state of the art. Haematologica, 94, 451–454.
Levac, K., Menendez, P., & Bhatia, M. (2005). Intra-bone marrow transplantation facilitates pauci-clonal human hematopoietic repopulation of NOD/SCID/beta2m(−/−) mice. Experimental Hematology, 33, 1417–1426.
Menendez, P., Bueno, C., Wang, L., & Bhatia, M. (2005). Human embryonic stem cells: potential tool for achieving immunotolerance? Stem Cell Reviews, 1, 151–158.
Menendez, P., Perez-Simon, J. A., Mateos, M. V., Caballero, M. D., Gonzalez, M., et al. (2002). Influence of the different CD34+ and CD34- cell subsets infused on clinical outcome after non-myeloablative allogeneic peripheral blood transplantation from human leucocyte antigen-identical sibling donors. British Journal Haematology, 119, 135–143.
Menendez, P., Prosper, F., Bueno, C., Arbona, C., San Miguel, J. F., et al. (2001). Sequential analysis of CD34+ and CD34- cell subsets in peripheral blood and leukapheresis products from breast cancer patients mobilized with SCF plus G-CSF and cyclophosphamide. Leukemia, 15, 430–439.
Berz, D., McCormack, E. M., Winer, E. S., Colvin, G. A., & Quesenberry, P. J. (2007). Cryopreservation of hematopoietic stem cells. American Journal of Hematology, 82, 463–472.
Bueno, C., Catalina, P., Melen, G. J., Montes, R., Sanchez, L., et al. (2009). Etoposide induces MLL rearrangements and other chromosomal abnormalities in human embryonic stem cells. Carcinogenesis, 30, 1628–1637.
Bueno, C., Montes, R., De la Cueva, T., Gutierrez-Aranda, I., & Menendez, P. (2009). Intra-bone marrow transplantation of human CD34+ cells into NOD/LtSz-scid IL2rg null mice permits multilineage engraftment without previous irradiation Cytotherapy (in press).
Bueno, C., Montes, R., Martin, L., Prat, I., Hernandez, M. C., et al. (2008). NG2 antigen is expressed in CD34+ HPCs and plasmacytoid dendritic cell precursors: is NG2 expression in leukemia dependent on the target cell where leukemogenesis is triggered? Leukemia, 22, 1475–1478.
Clarke, D. M., Yadock, D. J., Nicoud, I. B., Mathew, A. J., & Heimfeld, S. (2009). Improved post-thaw recovery of peripheral blood stem/progenitor cells using a novel intracellular-like cryopreservation solution. Cytotherapy, 11, 472–479.
Tijssen, M. R., Woelders, H., de Vries-van, R. A., van der Schoot, C. E., Voermans, C., et al. (2008). Improved postthaw viability and in vitro functionality of peripheral blood hematopoietic progenitor cells after cryopreservation with a theoretically optimized freezing curve. Transfusion, 48, 893–901.
Heng, B. C., Ye, C. P., Liu, H., Toh, W. S., Rufaihah, A. J., et al. (2006). Loss of viability during freeze-thaw of intact and adherent human embryonic stem cells with conventional slow-cooling protocols is predominantly due to apoptosis rather than cellular necrosis. Journal of Biomedical Science, 13, 433–445.
Cortes, J. L., Sanchez, L., Ligero, G., Gutierrez-Aranda, I., Catalina, P., et al. (2009). Mesenchymal stem cells facilitate the derivation of human embryonic stem cells from cryopreserved poor-quality embryos. Human Reproduction, 24, 1844–1851.
Gauthaman, K., Fong, C.-Y., & Bongso, A. (2010). Effect of ROCK Inhibitor Y-27632 on Normal and Variant Human Embryonic Stem Cells (hESCs) In Vitro: Its Benefits in hESC Expansion Stem Cell Rev (in press).
Krawetz, R. J., Li, X., & Rancourt, D. E. (2009). Human embryonic stem cells: caught between a ROCK inhibitor and a hard place. Bioessays, 31, 336–343.
Li, X., Krawetz, R., Liu, S., Meng, G., & Rancourt, D. E. (2009). ROCK inhibitor improves survival of cryopreserved serum/feeder-free single human embryonic stem cells. Human Reproduction, 24, 580–589.
Li, X., Meng, G., Krawetz, R., Liu, S., & Rancourt, D. E. (2008). The ROCK inhibitor Y-27632 enhances the survival rate of human embryonic stem cells following cryopreservation. Stem Cells and Development, 17, 1079–1085.
Martin-Ibanez, R., Unger, C., Stromberg, A., Baker, D., Canals, J. M., et al. (2008). Novel cryopreservation method for dissociated human embryonic stem cells in the presence of a ROCK inhibitor. Human Reproduction, 23, 2744–2754.
Pakzad, M., Totonchi, M., Taei, A., Seifinejad, A., Hassani, S., et al. (2010). Presence of a ROCK inhibitor in extracellular matrix supports more undifferentiated growth of feeder-free human embryonic and induced pluripotent stem cells upon passaging. Stem Cell Reviews (in press).
Watanabe, K., Ueno, M., Kamiya, D., Nishiyama, A., Matsumura, M., et al. (2007). A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nature Biotechnology, 25, 681–686.
Claassen, D. A., Desler, M. M., & Rizzino, A. (2009). ROCK inhibition enhances the recovery and growth of cryopreserved human embryonic stem cells and human induced pluripotent stem cells. Molecular Reproduction and Development, 76, 722–732.
Heng, B. C. (2009). Effect of Rho-associated kinase (ROCK) inhibitor Y-27632 on the post-thaw viability of cryopreserved human bone marrow-derived mesenchymal stem cells. Tissue and Cell, 41, 376–380.
Menendez, P., Wang, L., Chadwick, K., Li, L., & Bhatia, M. (2004). Retroviral transduction of hematopoietic cells differentiated from human embryonic stem cell-derived CD45(neg)PFV hemogenic precursors. Molecular Therapy, 10, 1109–1120.
Catalina, P., Bueno, C., Montes, R., Nieto, A., Ligero, G., et al. (2009). Genetic stability of human embryonic stem cells: a first-step toward the development of hESC-based system for modelling childhhod leukemia. Leukemia Research, 33, 980–990.
Catalina, P., Montes, R., Ligero, G., Sanchez, L., de la Cueva, T., et al. (2008). Human ESCs predisposition to karyotypic instability: is a matter of culture adaptation or differential vulnerability among hESC lines due to inherent properties? Molecular Cancer, 7, 76–81.
Wang, L., Menendez, P., Cerdan, C., & Bhatia, M. (2005). Hematopoietic development from human embryonic stem cell lines. Experimental Hematology, 33, 987–996.
Menendez, P., Caballero, M. D., Prosper, F., Del Canizo, M. C., Perez-Simon, J. A., et al. (2002). The composition of leukapheresis products impacts on the hematopoietic recovery after autologous transplantation independently of the mobilization regimen. Transfusion, 42, 1159–1172.
Prosper, F., Sola, C., Hornedo, J., Arbona, C., Menendez, P., et al. (2003). Mobilization of peripheral blood progenitor cells with a combination of cyclophosphamide, r-metHuSCF and filgrastim in patients with breast cancer previously treated with chemotherapy. Leukemia, 17, 437–441.
Stockschlader, M., Hassan, H. T., Krog, C., Kruger, W., Loliger, C., et al. (1997). Long-term follow-up of leukaemia patients after related cryopreserved allogeneic bone marrow transplantation. British Journal Haematology, 96, 382–386.
Hall, A. (1994). Small GTP-binding proteins and the regulation of the actin cytoskeleton. Annual Review of Cell Biology, 10, 31–54.
Koyanagi, M., Takahashi, J., Arakawa, Y., Doi, D., Fukuda, H., et al. (2008). Inhibition of the Rho/ROCK pathway reduces apoptosis during transplantation of embryonic stem cell-derived neural precursors. Journal of Neuroscience Research, 86, 270–280.
Acknowledgments
This work was funded by the CSJA (0029 and 0030 to P.M) and CICE (P08-CTS-3678 to P.M) de la Junta de Andalucía, The Spanish Ministry of Health to P.M (PI070026) and C.B (CP07/00059) and the MICINN to P.M (PLE-2009-0111).
Authorship
C.B: designed and performed experiments, analysed the data and wrote the manuscript. R.M: performed experiments and analysed the data. P.M: conceived and supervised the study and wrote the paper. We thank Dr. René Rodriguez for helpful discussions and Dr Isidro Prat and M.C Rodríguez Lamas for provision of CB Units.
Conflict of Interest Disclosures
The authors reported no potential conflicts of interest.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Clara Bueno and Rosa Montes contributed equally to this work.
Rights and permissions
About this article
Cite this article
Bueno, C., Montes, R. & Menendez, P. The ROCK Inhibitor Y-27632 Negatively Affects the Expansion/Survival of Both Fresh and Cryopreserved Cord Blood-Derived CD34+ Hematopoietic Progenitor Cells. Stem Cell Rev and Rep 6, 215–223 (2010). https://doi.org/10.1007/s12015-010-9118-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12015-010-9118-5